Viewing Study NCT06754267

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:53 AM
Ignite Modification Date: 2026-05-21 @ 8:01 PM
Study NCT ID: NCT06754267
Status: RECRUITING
Last Update Posted: 2024-12-31
First Post: 2024-12-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Venetoclax Combined With Olverembatinib and Predinisone in Treating Ph+ B-ALL
Sponsor: First Affiliated Hospital of Zhejiang University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Precursor B-Cell Acute Lymphoblastic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None acute lymphoblastic leukemia View
None Ph chromosome View
None BCL2 inhibitor View
None TKI View